{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:25:07Z","timestamp":1790904307586,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss Paraplegic Foundation"},{"name":"Swiss Olympic"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal cord injury (SCI) may cause an autonomic imbalance in the gastrointestinal tract, leading to deficits in colonic motility, mucosal secretions, vascular tone, and an increase of intestinal barrier permeability. Autonomic denervation and factors such as age, physical activity, antibiotic use and stress may cause intestinal bacterial translocation, decreased microbiota diversity, known as gut dysbiosis and thus increase susceptibility to experiencing gastrointestinal discomfort. Probiotic treatment in individuals with SCI may normalize the gut microbiota and improve overall health. We aim to assess the feasibility of probiotic and prebiotic intervention in athletes with SCI and collect information necessary for sample size calculation of a definite trial on improving health outcomes in para-athletes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and analysis<\/jats:title>\n                <jats:p>Elite Swiss para-athletes (aged&gt; 18 years), being shortlisted for the Paralympic Games 2021 in Tokyo or a member of a national team (<jats:italic>n<\/jats:italic> = 43), will be invited to participate in this single-center randomized crossover trial. Athletes suffering from chronic inflammatory bowel diseases, those currently taking antibiotics or other medication to alleviate gastro-intestinal complaints will not be eligible to be included in the study. Athletes will be randomized (1:1) to receive for 4 weeks a daily dose of either 3 g of probiotic preparation or 5 g of prebiotic (organic oat bran) supplementation in addition to usual diet, followed by a 4-week washout period or vice versa. The primary outcome is the feasibility of the study, measured by recruitment and dropout rates, feasibility of the measurements, acceptability and adherence to the intervention. Secondary outcomes include gastrointestinal health assessment, diet and training information, handgrip strength, blood diagnostic parameters, and intestinal microbiome characterization. The changes in clinically relevant secondary outcome values will be used to make a power calculation for definite trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This pilot trial will address two common challenges in SCI research: the difficulty to recruit enough participants for a sufficiently powered study and the ability to collect data within the limits of a realistic budget and time frame. Upon demonstrated feasibility of the intervention and study procedures, the intervention will be evaluated in a definitive controlled trial comprising a larger sample of para-athletes (elite, engaged, or recreationally active) individuals with a SCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04659408\">NCT04659408<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40814-022-01048-6","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T09:04:30Z","timestamp":1651050270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The feasibility of a crossover, randomized controlled trial design to assess the effect of probiotics and prebiotics on health of elite Swiss para-athletes: a study protocol"],"prefix":"10.1186","volume":"8","author":[{"given":"Marija","family":"Glisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle L.","family":"Flueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Ruettimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Hertig-Godeschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Valido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Stucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-6284","authenticated-orcid":false,"given":"Jivko","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"1","key":"1048_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s13311-017-0583-2","volume":"15","author":"KA Kigerl","year":"2018","unstructured":"Kigerl KA, Mostacada K, Popovich PG. Gut microbiota are disease-modifying factors after traumatic spinal cord injury. Neurotherapeutics. 2018;15(1):60\u20137.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"1048_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/sj.sc.3101066","volume":"38","author":"K Krogh","year":"2000","unstructured":"Krogh K, Mosdal C, Laurberg S. Gastrointestinal and segmental colonic transit times in patients with acute and chronic spinal cord lesions. Spinal Cord. 2000;38(10):615\u201321.","journal-title":"Spinal Cord"},{"issue":"2","key":"1048_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1600-0404.2011.01508.x","volume":"125","author":"L Fynne","year":"2012","unstructured":"Fynne L, Worsoe J, Gregersen T, Schlageter V, Laurberg S, Krogh K. Gastric and small intestinal dysfunction in spinal cord injury patients. Acta Neurol Scand. 2012;125(2):123\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"1048_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1440-1746.2007.04933.x","volume":"22","author":"S Balzan","year":"2007","unstructured":"Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2007;22(4):464\u201371.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"1048_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120(7):1183\u201396.","journal-title":"Circ Res"},{"issue":"17","key":"1048_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"1048_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-020-00813-7","volume":"13","author":"ER Leeming","year":"2021","unstructured":"Leeming ER, Louca P, Gibson R, Menni C, Spector TD, Le Roy CI. The complexities of the diet-microbiome relationship: advances and perspectives. Genome Med. 2021;13(1):10.","journal-title":"Genome Med"},{"issue":"4","key":"1048_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1310\/sci2404-379","volume":"24","author":"MS Nash","year":"2018","unstructured":"Nash MS, Groah SL, Gater DR Jr, Dyson-Hudson TA, Lieberman JA, Myers J, et al. Identification and management of cardiometabolic risk after spinal cord injury: clinical practice guideline for health care providers. Top Spinal Cord Inj Rehabil. 2018;24(4):379\u2013423.","journal-title":"Top Spinal Cord Inj Rehabil"},{"issue":"1","key":"1048_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/10790268.2001.11753551","volume":"24","author":"Y Szlachcic","year":"2001","unstructured":"Szlachcic Y, Adkins RH, Adal T, Yee F, Bauman W, Waters RL. The effect of dietary intervention on lipid profiles in individuals with spinal cord injury. J Spinal Cord Med. 2001;24(1):26\u20139.","journal-title":"J Spinal Cord Med"},{"issue":"2","key":"1048_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nut.2011.04.007","volume":"28","author":"H Sabour","year":"2012","unstructured":"Sabour H, Javidan AN, Vafa MR, Shidfar F, Nazari M, Saberi H, et al. Calorie and macronutrients intake in people with spinal cord injuries: an analysis by sex and injury-related variables. Nutrition. 2012;28(2):143\u20137.","journal-title":"Nutrition"},{"issue":"4","key":"1048_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.apmr.2004.10.023","volume":"86","author":"KM Tomey","year":"2005","unstructured":"Tomey KM, Chen DM, Wang X, Braunschweig CL. Dietary intake and nutritional status of urban community-dwelling men with paraplegia. Arch Phys Med Rehabil. 2005;86(4):664\u201371.","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"1048_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1179\/2045772313Y.0000000180","volume":"37","author":"J Lieberman","year":"2014","unstructured":"Lieberman J, Goff D Jr, Hammond F, Schreiner P, Norton HJ, Dulin M, et al. Dietary intake and adherence to the 2010 Dietary Guidelines for Americans among individuals with chronic spinal cord injury: a pilot study. J Spinal Cord Med. 2014;37(6):751\u20137.","journal-title":"J Spinal Cord Med"},{"issue":"8","key":"1048_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.sc.3101179","volume":"39","author":"R Aquilani","year":"2001","unstructured":"Aquilani R, Boschi F, Contardi A, Pistarini C, Achilli MP, Fizzotti G, et al. Energy expenditure and nutritional adequacy of rehabilitation paraplegics with asymptomatic bacteriuria and pressure sores. Spinal Cord. 2001;39(8):437\u201341.","journal-title":"Spinal Cord"},{"issue":"6","key":"1048_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1179\/2045772311Y.0000000026","volume":"34","author":"C Perret","year":"2011","unstructured":"Perret C, Stoffel-Kurt N. Comparison of nutritional intake between individuals with acute and chronic spinal cord injury. J Spinal Cord Med. 2011;34(6):569\u201375.","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"1048_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41393-018-0218-4","volume":"57","author":"GJ Farkas","year":"2019","unstructured":"Farkas GJ, Pitot MA, Berg AS, Gater DR. Nutritional status in chronic spinal cord injury: a systematic review and meta-analysis. Spinal Cord. 2019;57(1):3\u201317.","journal-title":"Spinal Cord"},{"issue":"3","key":"1048_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jand.2015.12.006","volume":"116","author":"DT Thomas","year":"2016","unstructured":"Thomas DT, Erdman KA, Burke LM. Position of the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance. J Acad Nutr Diet. 2016;116(3):501\u201328.","journal-title":"J Acad Nutr Diet"},{"issue":"2","key":"1048_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MOG.0000000000000240","volume":"32","author":"O Cronin","year":"2016","unstructured":"Cronin O, Molloy MG, Shanahan F. Exercise, fitness, and the gut. Curr Opin Gastroenterol. 2016;32(2):67\u201373.","journal-title":"Curr Opin Gastroenterol"},{"key":"1048_CR18","doi-asserted-by":"publisher","first-page":"3831972","DOI":"10.1155\/2017\/3831972","volume":"2017","author":"V Monda","year":"2017","unstructured":"Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev. 2017;2017:3831972.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"1048_CR19","first-page":"625","volume":"67","author":"W Barton","year":"2018","unstructured":"Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, et al. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67(4):625\u201333.","journal-title":"Gut"},{"issue":"2","key":"1048_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/nu11020261","volume":"11","author":"N Murtaza","year":"2019","unstructured":"Murtaza N, Burke LM, Vlahovich N, Charlesson B, O\u2019Neill H, Ross ML, et al. The effects of dietary pattern during intensified training on stool microbiota of elite race walkers. Nutrients. 2019;11(2):261.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"1048_CR21","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1007\/s40279-014-0153-2","volume":"44","author":"EP de Oliveira","year":"2014","unstructured":"de Oliveira EP, Burini RC, Jeukendrup A. Gastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendations. Sports Med (Auckland, N.Z.). 2014;44(Suppl 1):S79\u201385.","journal-title":"Sports Med (Auckland, N.Z.)"},{"issue":"3","key":"1048_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/nu8030173","volume":"8","author":"JY Yoo","year":"2016","unstructured":"Yoo JY, Kim SS. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 2016;8(3):173.","journal-title":"Nutrients"},{"key":"1048_CR23","doi-asserted-by":"publisher","first-page":"127982","DOI":"10.1016\/j.foodchem.2020.127982","volume":"338","author":"PF Raguindin","year":"2021","unstructured":"Raguindin PF, Adam Itodo O, Stoyanov J, Dejanovic GM, Gamba M, Asllanaj E, et al. A systematic review of phytochemicals in oat and buckwheat. Food Chem. 2021;338:127982.","journal-title":"Food Chem"},{"issue":"1","key":"1048_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12970-019-0329-0","volume":"16","author":"R Jager","year":"2019","unstructured":"Jager R, Mohr AE, Carpenter KC, Kerksick CM, Purpura M, Moussa A, et al. International society of sports nutrition position stand: probiotics. J Int Soc Sports Nutr. 2019;16(1):62.","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"1048_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (London, England). 2012;10(1):28\u201355.","journal-title":"Int J Surg (London, England)"},{"key":"1048_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/0470854596","volume-title":"Cross-over trials in clinical research","author":"SS Senn","year":"2002","unstructured":"Senn SS. Cross-over trials in clinical research. 2nd ed. San Francisco: Wiley; 2002.","edition":"2"},{"issue":"3","key":"1048_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057\u201373.","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"1048_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/nutrit\/nuz064","volume":"78","author":"R Korczak","year":"2020","unstructured":"Korczak R, Kocher M, Swanson KS. Effects of oats on gastrointestinal health as assessed by in vitro, animal, and human studies. Nutr Rev. 2020;78(5):343\u201363.","journal-title":"Nutr Rev"},{"issue":"Suppl 1","key":"1048_CR29","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1079\/BJN20041350","volume":"93","author":"MB Roberfroid","year":"2005","unstructured":"Roberfroid MB. Introducing inulin-type fructans. Br J Nutr. 2005;93(Suppl 1):S13\u201325.","journal-title":"Br J Nutr"},{"issue":"3","key":"1048_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1037\/1082-989X.8.3.322","volume":"8","author":"CK Enders","year":"2003","unstructured":"Enders CK. Using the expectation maximization algorithm to estimate coefficient alpha for scales with item-level missing data. Psychol Methods. 2003;8(3):322\u201337.","journal-title":"Psychol Methods"},{"issue":"4","key":"1048_CR31","first-page":"264","volume":"64","author":"E Eypasch","year":"1993","unstructured":"Eypasch E, Wood-Dauphinee S, Williams JI, Ure B, Neugebauer E, Troidl H. The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg. 1993;64(4):264\u201374.","journal-title":"Chirurg"},{"issue":"4","key":"1048_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.apmr.2011.11.005","volume":"93","author":"KA Martin Ginis","year":"2012","unstructured":"Martin Ginis KA, Phang SH, Latimer AE, Arbour-Nicitopoulos KP. Reliability and validity tests of the leisure time physical activity questionnaire for people with spinal cord injury. Arch Phys Med Rehabil. 2012;93(4):677\u201382.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"1048_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bjsports-2016-096669","volume":"51","author":"A Hirschm\u00fcller","year":"2017","unstructured":"Hirschm\u00fcller A, Steffen K, Fassbender K, Clarsen B, Leonhard R, Konstantinidis L, et al. German translation and content validation of the OSTRC Questionnaire on overuse injuries and health problems. Br J Sports Med. 2017;51(4):260\u20133.","journal-title":"Br J Sports Med"},{"key":"1048_CR34","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.","journal-title":"BMJ"},{"key":"1048_CR35","doi-asserted-by":"publisher","DOI":"10.1201\/9780203911341","volume-title":"Sample size calculations in clinical research","author":"SC Chow","year":"2003","unstructured":"Chow SC, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. New York: Chapman and Hall\/CRC Press; 2003."},{"issue":"6","key":"1048_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1740774517724165","volume":"14","author":"O Brosteanu","year":"2017","unstructured":"Brosteanu O, Schwarz G, Houben P, Paulus U, Strenge-Hesse A, Zettelmeyer U, et al. Risk-adapted monitoring is not inferior to extensive on-site monitoring: results of the ADAMON cluster-randomised study. Clin Trials. 2017;14(6):584\u201396.","journal-title":"Clin Trials"},{"issue":"10","key":"1048_CR37","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3748\/wjg.v21.i10.3072","volume":"21","author":"T Didari","year":"2015","unstructured":"Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol. 2015;21(10):3072\u201384.","journal-title":"World J Gastroenterol"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-022-01048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-022-01048-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-022-01048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T09:04:37Z","timestamp":1651050277000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-022-01048-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s40814-022-01048-6","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers will be followed during the course of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}